Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...

Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible ...

HealthDay News — Once-daily oral zasocitinib (TAK-279), an oral tyrosine kinase 2 (TYK2) inhibitor, provides a durable response in adults with moderate-to-severe plaque psoriasis (PsO), according to a ...

Please provide your email address to receive an email when new articles are posted on . Nearly 90% of participants receiving bimekizumab reached on-treatment remission for 6 months. More than half ...

Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...

Many people with psoriasis notice their skin clears up after spending some time in the sun. Others experience irritation, ...

Persistent itching, red patches, and inflamed skin are common complaints, but not all skin conditions are the same. Two of the most frequently confused disorders are eczema and psoriasis, both chronic ...

Learn how rotational therapy for psoriasis has evolved with the advent of safer, more effective biologic therapies.

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced IMULDOSA® (ustekinumab-srlf) is now covered by ...

Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...